{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:13:34Z","timestamp":1793038414853,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.diabres.2023.110855","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:53:06Z","timestamp":1690530786000},"page":"110855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register"],"prefix":"10.1016","volume":"203","author":[{"given":"Lee-Ling","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"S. H. Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew","family":"Pheng Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinart","family":"Sirinvaravong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"O. Y. Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"C. N. Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110855_b0005","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https:\/\/www.diabetesatlas.org."},{"key":"10.1016\/j.diabres.2023.110855_b0010","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.diabres.2023.110855_b0015","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0165-0327(12)70009-5","article-title":"Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge","volume":"142","author":"Fisher","year":"2012","journal-title":"J Affect Disord"},{"issue":"45","key":"10.1016\/j.diabres.2023.110855_b0020","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"2022","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110855_b0025","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes\u20142022. Diabetes Care 2021;45:S46\u2013S59.","DOI":"10.2337\/dc22-S004"},{"key":"10.1016\/j.diabres.2023.110855_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108974","article-title":"Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study","volume":"180","author":"Nicolucci","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110855_b0035","first-page":"1666","article-title":"Effect of Glimepiride on Health Related Quality of Life in Type 2 Diabetes Mellitus","volume":"6","author":"Panda","year":"2015","journal-title":"Res J Pharmaceut Biol Chem Sci"},{"key":"10.1016\/j.diabres.2023.110855_b0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5530\/ijpi.2021.3.58","article-title":"Association of Insulin Therapy with Depression, Cognition and Quality of Life in Type 2 Diabetes Patients: A Cross-sectional Study","volume":"11","author":"Parveen","year":"2021","journal-title":"Int J Pharm Investigation"},{"key":"10.1016\/j.diabres.2023.110855_b0045","first-page":"293","volume":"29","author":"Barendse","year":"2012","journal-title":"The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabet Med"},{"key":"10.1016\/j.diabres.2023.110855_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109218","article-title":"Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study","volume":"185","author":"Nicolucci","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110855_b0055","article-title":"Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register","author":"Lim","year":"202325208","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2023.110855_b0060","first-page":"2","article-title":"Health-related quality of life in Chinese patients with type 2 diabetes: An analysis of the Joint Asia Diabetes Evaluation (JADE) Program","volume":"5","author":"Luk","year":"2014","journal-title":"J Diabetes Metab"},{"key":"10.1016\/j.diabres.2023.110855_b0065","doi-asserted-by":"crossref","first-page":"e1003367","DOI":"10.1371\/journal.pmed.1003367","article-title":"Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis","volume":"17","author":"Lim","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2023.110855_b0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/dom.13950","article-title":"Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register","volume":"22","author":"Kong","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2023.110855_b0075","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice C. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S17-S38.","DOI":"10.2337\/dc22-S002"},{"key":"10.1016\/j.diabres.2023.110855_b0080","unstructured":"https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-3l-about\/valuation\/; accessed 10 July 2023."},{"key":"10.1016\/j.diabres.2023.110855_b0085","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/bcp.13059","article-title":"Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis","volume":"82","author":"Andersen","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2023.110855_b0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13300-014-0082-y","article-title":"Higher risk of hypoglycemia with glimepiride versus vildagliptin in patients with type 2 diabetes is not driven by high doses of glimepiride: divergent patient susceptibilities?","volume":"5","author":"Ahr\u00e9n","year":"2014","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2023.110855_b0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.diabres.2010.12.027","article-title":"Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus","volume":"91","author":"Williams","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110855_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-8-86","article-title":"Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study","volume":"8","author":"Alvarez-Guisasola","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.diabres.2023.110855_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0168-8227(92)90146-I","article-title":"Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function","volume":"18","author":"Gregorio","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110855_b0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/diacare.17.2.142","article-title":"Slow Elimination of Glyburide in NIDDM Subjects","volume":"17","author":"J\u00f6nsson","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110855_b0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4239\/wjd.v5.i5.651","article-title":"Diabetes treatment in patients with renal disease: Is the landscape clear enough?","volume":"5","author":"Ioannidis","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabres.2023.110855_b0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.diabres.2015.07.002","article-title":"Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents","volume":"110","author":"Chan","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110855_b0125","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cpt.1307","article-title":"A model-based meta-analysis of 24 antihyperglycemic drugs for type 2 diabetes: comparison of treatment effects at therapeutic doses","volume":"105","author":"Maloney","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.diabres.2023.110855_b0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2710.2009.01134.x","article-title":"Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers","volume":"35","author":"Shao","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.diabres.2023.110855_b0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cpt.2446","article-title":"CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes","volume":"111","author":"Wang","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.diabres.2023.110855_b0140","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update","volume":"60","author":"National Kidney Foundation","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2023.110855_b0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13300-021-01002-4","article-title":"The Position of Gliclazide in the Evolving Landscapes and Disease Continuum of T2DM: A Collaborative Delphi Survey-Based Consensus from India","volume":"12","author":"Kalra","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2023.110855_b0150","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s11136-016-1324-4","article-title":"Main predictors in health-related quality of life in Chinese patients with type 2 diabetes mellitus","volume":"25","author":"Wan","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.diabres.2023.110855_b0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1753-0407.12262","article-title":"Gender, diabetes education, and psychosocial factors are associated with persistent poor glycemic control in patients with type 2 diabetes in the Joint Asia Diabetes Evaluation (JADE) program","volume":"8","author":"Yin","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2023.110855_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-017-0187-1","article-title":"Health-related quality of life in type-2 diabetes patients: a cross-sectional study in East China","volume":"17","author":"Lu","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.diabres.2023.110855_b0165","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/(SICI)1096-9136(1998120)15:4+<S41::AID-DIA747>3.0.CO;2-E","article-title":"The elderly Type 2 diabetic patient: special considerations","volume":"15","author":"Morley","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2023.110855_b0170","first-page":"100663","article-title":"Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: A cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program","volume":"32","author":"Lim","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.diabres.2023.110855_b0175","doi-asserted-by":"crossref","first-page":"e192696","DOI":"10.1001\/jamanetworkopen.2019.2696","article-title":"Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants","volume":"2","author":"Yang","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.diabres.2023.110855_b0180","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1210\/clinem\/dgab434","article-title":"The Integration of Sex and Gender Considerations Into Biomedical Research: Lessons From International Funding Agencies","volume":"106","author":"White","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.110855_b0185","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/diacare.20.4.562","article-title":"Quality of Life and Associated Characteristics in a Large National Sample of Adults With Diabetes","volume":"20","author":"Glasgow","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110855_b0190","first-page":"179","article-title":"Health-related quality of life among North Carolina adults with diabetes mellitus","volume":"66","author":"Wubben","year":"2005","journal-title":"N C Med J"},{"key":"10.1016\/j.diabres.2023.110855_b0195","doi-asserted-by":"crossref","first-page":"e0140599","DOI":"10.1371\/journal.pone.0140599","article-title":"Health-related quality of life in relation to obesity grade, type 2 diabetes, metabolic syndrome and inflammation","volume":"10","author":"Slagter","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2023.110855_b0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2023.110855_b0205","doi-asserted-by":"crossref","unstructured":"The Look AHEAD Research Group. Impact of Intensive Lifestyle Intervention on Depression and Health-Related Quality of Life in Type 2 Diabetes: The Look AHEAD Trial. Diabetes Care. 2014;37:1544-53.","DOI":"10.2337\/dc13-1928"},{"key":"10.1016\/j.diabres.2023.110855_b0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1015287825660","article-title":"The influence of cardiovascular disease on quality of life in type 2 diabetics","volume":"11","author":"de Visser","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.diabres.2023.110855_b0215","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2337\/dc07-2072","article-title":"Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4)","volume":"31","author":"Kleefstra","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110855_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MLR.0b013e3181844855","article-title":"Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes","volume":"47","author":"Clarke","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.diabres.2023.110855_b0225","doi-asserted-by":"crossref","first-page":"4360804","DOI":"10.1155\/2020\/4360804","article-title":"Effects of diabetic complications on health-related quality of life impairment in Vietnamese patients with type 2 diabetes","volume":"2020","author":"Pham","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2023.110855_b0230","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.3390\/ijerph16193561","article-title":"Quality of life and associated factors among primary care Asian patients with type 2 diabetes mellitus","volume":"16","author":"Dhillon","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.diabres.2023.110855_b0235","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijerph16152652","article-title":"Decreased quality of life in individuals with type 2 diabetes mellitus is associated with emotional distress","volume":"16","author":"G\u00f3mez-Pimienta","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.diabres.2023.110855_b0240","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11606-018-4705-2","article-title":"The importance of addressing depression and diabetes distress in adults with type 2 diabetes","volume":"34","author":"Owens-Gary","year":"2019","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.diabres.2023.110855_b0245","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes\u20142022. Diabetes Care. 2022;45:S8-S16.","DOI":"10.2337\/dc22-S001"},{"key":"10.1016\/j.diabres.2023.110855_b0250","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.2337\/dci19-0003","article-title":"From Hong Kong Diabetes Register to JADE Program to RAMP-DM for data-driven actions","volume":"42","author":"Chan","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723006186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723006186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T03:45:06Z","timestamp":1736394306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723006186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"alternative-id":["S0168822723006186"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110855","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110855"}}